News
September 2014

Now  2014 Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan 
Search  2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

Tenth of antibiotics prescribed by GPs over 22 years fail to cure patients
A 22-year study by Cardiff University has found that more than one in 10 of all antibiotic treatments in a primary care setting failed. This rate has increased and continues to rise. 26 Sept 2014

AstraZeneca and Cancer Research UK establish Cambridge lab to develop cancer drugs
MedImmune, the global biologics research and development arm of AstraZeneca and Cancer Research UK, with its commercial arm, Cancer Research Technology (CRT), are establishing a joint laboratory in Cambridge, UK to study novel biologic cancer treatments. 26 Sept 2014

University of Pittsburgh awarded $5.8m to develop 3D microfluidic model of the liver
The University of Pittsburgh School of Medicine has won $5.8 million grant from the National Institutes of Health (NIH) to further develop a microfluidic 3D model system that mimics the structure and function of the liver. 26 Sept 2014

Invest in Photonics chooses 20 European companies to pitch for €70m funding
Invest in Photonics 2014, a two-day international business partnering convention for photonics VC investment, has announced the selection of 20 emerging technology companies from around Europe to participate in a special funding session. 23 Sept 2014

Mayden awards contract to HealthMotive for NHS Spine integration software
Cloud solution developer Mayden has entered into a contract with healthcare systems developer  HealthMotive to incorporate HealthMotive’s Spin Messaging Handler (SMH) product into Mayden’s product offering. 23 Sept 2014

Sheffield displays the latest in robotics in Festival of the Mind
The University of Sheffield is holding a unique series of lectures between 19-25 September, focusing on the latest advancements in robotics and what the future has in store. 19 Sept 2014

electroCore to present at European headache meeting on non-invasive vagus nerve stimulation therapy for cluster headache
The company will be presenting full data on their PREVA study, a randomized, multi-centre trial across several European countries at the EHMTIC meeting in Copenhaghen. 18 Sept 2014

Exco InTouch selected to present on mHealth innovation at HealthXL event in San Francisco
The company is presenting on its role as a key innovator in digital patient engagement and data capture solutions for clinical research at the HealthXL conference. 18 Sept 2014

International Ebola response "Totally, and lethally inadequate" says MSF
The International President of Médicins Sans Frontières (MSF), Dr Joanne Liu, has told the UN that the world must act now to fight Ebola or many more people will die and that the response remains totally and lethally inadequate. 17 Sept 2014

Open Bionics 3D printed prosthetic hand reaches global finals of Intel competition
Robotics startup Open Bionics has seen its idea to significantly reduce the cost of prosthetic limbs by using 3D printing reach the global final of Intel's Make it Wearable Competition. 11 Sep 2014

QuantuMDx announces prototype handheld lab for rapid DNA diagnostics
Newcastle-based medical device developers QuantuMDx Group has announced the successful production of their first fully-integrated sample-to-result working prototype of Q-POC, a handheld lab that delivers DNA-based medical diagnosis in minutes. 11 Sep 2014

NHS information exchange backbone rebuilt and upgraded
NHS Spine, a set of applications, services and directories that underpin information exchange across the NHS in England, has been successfully rebuilt in a project led by the Health and Social Care Information Centre. 11 Sep 2014

Regions most at risk of Ebola mapped
An international team of researchers has mapped the regions in Africa most at risk of an Ebola outbreak based on animal infections. 9 Sept 2014

New technique to test for prostate cancer
A team of researchers at Guangdong Medical College in China has demonstrated the potential of a new test to detect prostate cancer combining surface-enhanced Raman scattering (SERS) with a new technique called support vector machine (SVM). 9 Sept 2014

Ultrathin coronary stent with biodegradable coating shows promise
A new generation of coronary artery stent that combines a biodegradable component with an ultrathin metal scaffold showed promising results compared with the current gold standard stent in a large study. 9 Sept 2014

New model predicts best distribution of AEDs to treat heart failure in public places
A new method to predict the optimal number and location of automated external defibrillators (AEDs), to treat members of the public suffering heart attacks, has been developed in Paris. 8 Sept 2014

Sugar in diet depletes good cholesterol
Scientists at the University of Warwick have discovered that the ‘good’ form of cholesterol, HDL, is degraded by a sugar-derived substance in the body. 8 Sept 2014

Roche launches automated molecular diagnostic systems for blood and blood plasma screening
Roche has launched two integrated and fully automated molecular testing systems for blood and plasma donor screening, the cobas 6800 and 8800, based on Nobel-prize winning PCR technology. 2 Sept 2014

Exco InTouch achieves a first with mobile health apps for iOS, Android and Windows8
Exco InTouch has announced the availability of electronic clinical outcomes assessment (eCOA) apps on all three mobile operating platforms (iOS, Android and Windows8). 2 Sept 2014

Medtronic acquires Sapiens Steering Brain Stimulation for $200m
Medtronic has announced that it has acquired privately held Dutch company Sapiens Steering Brain Stimulation for approximately $200 million in an all-cash transaction. The deal strengthens Medtronic's capabilities in the modulation of brain function. 2 Sept 2014

Boston Scientific takes over Bayer's vascular disease business for 300m
Boston Scientific Corporation and Bayer Healthcare have announced the closure of the previously announced agreement for Boston Scientific to  purchase the Interventional business of Bayer Healthcare. 2 Sept 2014

3D printing in reconstructive facial surgery hindered by reimbursement challenge
The 3D printing sector is battling to convince surgeons that it is a financially viable treatment for craniomaxillofacial (CMF) reconstruction, despite it being lauded as a game-changing development, says an analyst with research and consulting firm GlobalData. 1 Sept 2014

Aug 2014

Search...
2014 Jan | Feb | Mar | Apr | May | Jun | Jul | Aug
2013 Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2012 Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2011 Jan | Feb | Mar | Apr | May | JunJul | Aug | Sep | Oct | Nov | Dec
2010 Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec

2009
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2008 Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007 Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006 Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005 Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec

To top